2012年法国716,152例分娩中妊娠期糖尿病与不良围产结局
该研究从法国医院出院数据库和全国医保系统提取2012年孕22周后全部分娩数据,评估妊娠期糖尿病(GDM)的不良围产结局风险。共796,346例分娩中57,629例(7.24%)母亲患GDM,母子链接获705,198例。GDM不良结局风险远低于孕前糖尿病,但较非糖尿病 population 升高,胰岛素治疗GDM风险高于饮食治疗GDM。
要点
- GDM母亲57,629例,占全部796,346例分娩的7.24%;母子链接705,198例。
- GDM较非糖尿病 population 早产OR 1.3、剖宫产OR 1.4、子痫前期/子痫OR 1.7、巨大儿OR 1.8。
- 胰岛素治疗GDM多数结局风险高于饮食治疗GDM。
核心结论
- GDM与不良围产结局风险中度升高相关,且胰岛素治疗GDM在多数结局上风险高于非胰岛素治疗GDM。
研究设计与样本
- 研究纳入2012年法国孕22周后全部分娩,数据来自医院出院数据库和全国医保系统,共796,346例分娩,其中GDM母亲57,629例(7.24%),母子链接705,198例。
- 母亲糖尿病状态通过降糖药物使用和医院诊断确定,结局按糖尿病类型及GDM是否胰岛素治疗分析。
主要发现
- 限制在孕28周后分娩以降低不死时间偏倚后,GDM较非糖尿病 population 早产OR 1.3(95%CI 1.3, 1.4)、剖宫产OR 1.4(95%CI 1.4, 1.4)、子痫前期/子痫OR 1.7(95%CI 1.6, 1.7)、巨大儿OR 1.8(95%CI 1.7, 1.8)、呼吸窘迫OR 1.1(95%CI 1.0, 1.3)、产伤OR 1.3(95%CI 1.1, 1.5)、心脏畸形OR 1.3(95%CI 1.1, 1.4)。
- 胰岛素治疗GDM女性较饮食治疗GDM女性观察到更高风险。
- 限制足月分娩分析后,观察到围产期死亡风险增加。
- 排除疑似未诊断孕前糖尿病女性后,风险仅饮食治疗GDM者仍中度升高(OR 1.3 [95%CI 1.0, 1.6])。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this study was to assess the risk of adverse perinatal outcomes in gestational diabetes mellitus (GDM) in a large national cohort. METHODS: All deliveries taking place after 22 weeks in France in 2012 were included by extracting data from the hospital discharge database and the national health insurance system. The diabetic status of mothers was determined by the use of glucose-lowering agents and by hospital diagnosis. Outcomes were analysed according to the type of diabetes and, in the GDM group, whether or not diabetes was insulin-treated. RESULTS: The cohort of 796,346 deliveries involved 57,629 (7.24%) mothers with GDM. Mother-infant linkage was obtained for 705,198 deliveries. The risks of adverse outcomes were much lower with GDM than with pregestational diabetes. After limiting the analysis to deliveries after 28 weeks to reduce immortal time bias, the risks of preterm birth (OR 1.3 [95% CI 1.3, 1.4]), Caesarean section (OR 1.4 [95% CI 1.4, 1.4]), pre-eclampsia/eclampsia (OR 1.7 [95% CI 1.6, 1.7]), macrosomia (OR 1.8 [95% CI 1.7, 1.8]), respiratory distress (OR 1.1 [95% CI 1.0, 1.3]), birth trauma (OR 1.3 [95% CI 1.1, 1.5]) and cardiac malformations (OR 1.3 [95% CI 1.1, 1.4]) were increased in women with GDM compared with the non-diabetic population. Higher risks were observed in women with insulin-treated GDM than those with diet-treated GDM. After limiting the analysis to term deliveries, an increased risk of perinatal mortality was observed. After excluding women suspected to have undiagnosed pregestational diabetes, the risk remained moderately increased only for those with diet-treated GDM (OR 1.3 [95% CI 1.0, 1.6]). CONCLUSIONS/INTERPRETATION: GDM is associated with a moderately increased risk of adverse perinatal outcomes, which is higher in insulin-treated GDM than in non-insulin-treated GDM for most outcomes.
引用
- Billionnet C, Mitanchez D, Weill A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia. 2017. PMID: 28197657. doi:10.1007/s00125-017-4206-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。